Sarah Jefferies

6.8k total citations · 1 hit paper
122 papers, 3.8k citations indexed

About

Sarah Jefferies is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Sarah Jefferies has authored 122 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Genetics, 42 papers in Pulmonary and Respiratory Medicine and 26 papers in Epidemiology. Recurrent topics in Sarah Jefferies's work include Glioma Diagnosis and Treatment (44 papers), Brain Metastases and Treatment (19 papers) and Meningioma and schwannoma management (19 papers). Sarah Jefferies is often cited by papers focused on Glioma Diagnosis and Treatment (44 papers), Brain Metastases and Treatment (19 papers) and Meningioma and schwannoma management (19 papers). Sarah Jefferies collaborates with scholars based in United Kingdom, New Zealand and United States. Sarah Jefferies's co-authors include N.G. Burnet, Roger A’Hern, Christopher Scrase, R. Jena, F. Adab, Teresa Guerrero Urbano, James P. Morden, Catharine H. Clark, Mary Anne Tanay and Kevin J. Harrington and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.

In The Last Decade

Sarah Jefferies

117 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

2011 1.2k citations Christopher M. Nutting, James P. Morden et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Jefferies United Kingdom	32	1.3k	1.1k	922	772	771	122	3.8k
Henry S. Park United States	38	1.6k 1.2×	670 0.6×	279 0.3×	1.2k 1.5×	1.3k 1.7×	170	4.3k
Michael Poulsen Australia	38	1.5k 1.2×	1.5k 1.4×	253 0.3×	1.2k 1.5×	1.9k 2.5×	114	4.9k
Dirk Vordermark Germany	37	1.2k 0.9×	232 0.2×	558 0.6×	569 0.7×	1.1k 1.4×	222	4.7k
James D. Murphy United States	41	2.1k 1.6×	571 0.5×	183 0.2×	1.3k 1.7×	1.8k 2.4×	268	5.2k
Peter A.S. Johnstone United States	34	2.0k 1.5×	233 0.2×	270 0.3×	1.0k 1.3×	1.1k 1.4×	158	4.3k
Jan Paul de Boer Netherlands	35	788 0.6×	607 0.6×	324 0.4×	698 0.9×	1.6k 2.1×	118	3.9k
Ji‐An Liang Taiwan	34	1.1k 0.9×	388 0.4×	135 0.1×	935 1.2×	982 1.3×	208	4.0k
June Corry Australia	41	1.6k 1.2×	3.1k 2.9×	185 0.2×	2.1k 2.7×	1.7k 2.2×	142	5.4k
Sang-wook Lee South Korea	33	1.1k 0.9×	605 0.6×	114 0.1×	1.3k 1.6×	917 1.2×	188	3.6k
Chang Geol Lee South Korea	36	1.2k 1.0×	816 0.8×	120 0.1×	1.2k 1.6×	1.5k 1.9×	157	4.0k

Countries citing papers authored by Sarah Jefferies

Since Specialization

Citations

This map shows the geographic impact of Sarah Jefferies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Jefferies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Jefferies more than expected).

Fields of papers citing papers by Sarah Jefferies

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Jefferies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Jefferies. The network helps show where Sarah Jefferies may publish in the future.

Co-authorship network of co-authors of Sarah Jefferies

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Jefferies. A scholar is included among the top collaborators of Sarah Jefferies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Jefferies. Sarah Jefferies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brown, Nicholas F., Catherine McBain, Lucy Brazil, et al.. (2025). Ipilimumab with temozolomide vs. temozolomide alone after surgery and chemoradiotherapy in recently diagnosed glioblastoma: a randomized phase II clinical trial. Neuro-Oncology Advances. 7(1). vdaf032–vdaf032.

Bromhead, Collette, David Welch, Ernest Williams, et al.. (2025). Temporal reconstruction of a Salmonella Enteritidis ST11 outbreak in New Zealand. Microbial Genomics. 11(10).

Ince, Will, et al.. (2024). Squamous cell carcinoma of the oral cavity, oropharynx and upper oesophagus. Medicine. 52(3). 130–135. 1 indexed citations

Whitfield, Gillian, Helen Bulbeck, Laura Clifton‐Hadley, et al.. (2024). A Randomised Phase II Trial of Hippocampal Sparing Versus Conventional Whole Brain Radiotherapy After Surgical Resection or Radiosurgery in Favourable Prognosis Patients With 1–10 Brain Metastases. Clinical Oncology. 36(11). 681–689. 1 indexed citations

Brandner, Sebastian, Alexandra McAleenan, Hayley E Jones, et al.. (2021). Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta‐analysis based on a Cochrane systematic review. Neuropathology and Applied Neurobiology. 48(4). e12790–e12790. 18 indexed citations

Brennan, Paul M., Giles Critchley, Benjamin Hall, et al.. (2021). Second surgery for progressive glioblastoma: a multi‐centre questionnaire and cohort‐based review of clinical decision‐making and patient outcomes in current practice. Journal of Neuro-Oncology. 153(1). 99–107. 13 indexed citations

Brandner, Sebastian, Alexandra McAleenan, Claire Kelly, et al.. (2021). MGMTpromoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review. Neuro-Oncology. 23(9). 1457–1469. 39 indexed citations

Nguyen, Binh P., Joep de Ligt, Jemma L. Geoghegan, et al.. (2021). COVID-19 vaccine strategies for Aotearoa New Zealand: a mathematical modelling study. The Lancet Regional Health - Western Pacific. 15. 100256–100256. 14 indexed citations

Venkatesh, Ashwin, Kieren Allinson, Tilak Das, et al.. (2021). Response to BRAF and MEK1/2 inhibition in a young adult with BRAF V600E mutant epithelioid glioblastoma multiforme: A Case Report and Literature Review. Current Problems in Cancer. 45(5). 100701–100701. 7 indexed citations

10.

Hanna, Catherine, Theresa A Lawrie, Ewelina Rogozińska, et al.. (2020). Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis. Cochrane Database of Systematic Reviews. 2020(3). CD013261–CD013261. 49 indexed citations

11.

MacKeith, Samuel, Neil Donnelly, Richard Mannion, et al.. (2018). Aspirin does not prevent growth of vestibular schwannomas: A case‐control study. The Laryngoscope. 128(9). 2139–2144. 14 indexed citations

12.

Chalmers, Anthony J., Garth Cruickshank, Laurence Dunn, et al.. (2017). ACTR-16. RESULTS OF THE OPARATIC TRIAL: A PHASE I DOSE ESCALATION STUDY OF OLAPARIB IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN PATIENTS WITH RELAPSED GLIOBLASTOMA (GBM). Neuro-Oncology. 19(suppl_6). vi4–vi4. 14 indexed citations

13.

Sage, William M., Mathew R. Guilfoyle, Adam M. H. Young, et al.. (2017). Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit. Journal of Neuro-Oncology. 136(2). 273–280. 17 indexed citations

14.

Rampling, R., Paul Mulholland, Allan James, et al.. (2016). A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma. Clinical Cancer Research. 22(19). 4776–4785. 122 indexed citations

15.

Noble, David J., Daniel Scoffings, Thankamma Ajithkumar, M.V. Williams, & Sarah Jefferies. (2016). Fast imaging employing steady-state acquisition (FIESTA) MRI to investigate cerebrospinal fluid (CSF) within dural reflections of posterior fossa cranial nerves. British Journal of Radiology. 89(1067). 20160392–20160392. 20 indexed citations

16.

Ajithkumar, Thankamma, Christine Parkinson, Kate Fife, Pippa Corrie, & Sarah Jefferies. (2015). Evolving treatment options for melanoma brain metastases. The Lancet Oncology. 16(13). e486–e497. 65 indexed citations

17.

Booth, Thomas C., Adam Waldman, Sarah Jefferies, & Hans Rolf Jäger. (2014). Comment on “The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline” [J Neurooncol 2014; 118:435–460]. Journal of Neuro-Oncology. 121(2). 423–424. 4 indexed citations

18.

Nutting, Christopher M., James P. Morden, Kevin J. Harrington, et al.. (2011). Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. The Lancet Oncology. 12(2). 127–136. 1202 indexed citations breakdown →

19.

Burnet, N.G., et al.. (2004). The Anatomy of Sartorius Muscle and its Implications for Sarcoma Radiotherapy. Sarcoma. 8(1). 7–12. 9 indexed citations

20.

Sherr, Lorraine, Sarah Jefferies, & Christina Victor. (1992). General Practice Pregnancy Care and the Challenges of HIV. Aids Patient Care. 6(2). 62–66. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact